RxDoctor Payments Data

Carleton Vangsness

Sports Medicine · Los Angeles, CANPI 1609829746

Payments from drug & device makers

What this record shows

This record is dominated by ownership interests: $770,478 of the $872,117 with a category attached, or 88.3%. Anika Therapeutics, Inc. accounts for 99.9% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2020 at $770,478 and has fallen 86.9% since, to $100,871 in 2022. Among sports medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$872,117in general payments, 2019–2025

Across 7 payments — averaging $124,588 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Anika Therapeutics, Inc.$871K
  • Bioventus LLC$700
  • Smith+Nephew$47
  • Kinamed, Inc.$21

What the payments were for

  • Consulting fees$7000%
  • Food & beverage$680%
  • Ownership interest$770,47888%
  • Other$100,87112%

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Anika Therapeutics, Inc.4$871,349
Bioventus LLC1$700
Smith+Nephew1$47
Kinamed, Inc.1$21

How this compares

$872,117 in reported general payments places this provider in the 95th percentile of 662 sports medicine providers in California.

See all sports medicine providers in California

Other sports medicine in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →